Cargando…

Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy after alemtuzumab therapy in kidney transplant recipients

Detalles Bibliográficos
Autores principales:	van der Zwan, Marieke, Hesselink, Dennis A., Brusse, Esther, van Doorn, Pieter A., van den Hoogen, Martijn W.F., de Weerd, Annelies E., Jacobs, Bart C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2020
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7188471/ https://www.ncbi.nlm.nih.gov/pubmed/32299841 http://dx.doi.org/10.1212/NXI.0000000000000721

Ejemplares similares

Misdiagnosis and diagnostic pitfalls of chronic inflammatory demyelinating polyradiculoneuropathy
por: Broers, Merel C., et al.
Publicado: (2021)

Sex differences in Guillain Barré syndrome, chronic inflammatory demyelinating polyradiculoneuropathy and experimental autoimmune neuritis
por: McCombe, Pamela A., et al.
Publicado: (2022)

Differences in Thyroid Function and Autoantibodies in the Development of Guillain–Barré Syndrome vs. Chronic Inflammatory Demyelinating Polyradiculoneuropathy
por: Tu, Yu, et al.
Publicado: (2020)

Randomized trial of intravenous immunoglobulin maintenance treatment regimens in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, K., et al.
Publicado: (2020)

Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy
por: Kuitwaard, Krista, et al.
Publicado: (2021)

Costimulation Blockade in Kidney Transplant Recipients
por: van der Zwan, Marieke, et al.
Publicado: (2019)

Withdrawal of intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy
por: Adrichem, Max E., et al.
Publicado: (2022)

Epidemiology of chronic inflammatory demyelinating polyradiculoneuropathy in The Netherlands
por: Broers, Merel C., et al.
Publicado: (2022)

Relationship between cerebrospinal fluid protein level and electrophysiologic abnormalities in the acute inflammatory demyelinating polyradiculoneuropathy variant of Guillain-Barré syndrome
por: Jawaid, Wajid, et al.
Publicado: (2021)

Review of the Clinical Pharmacokinetics and Pharmacodynamics of Alemtuzumab and Its Use in Kidney Transplantation
por: van der Zwan, Marieke, et al.
Publicado: (2017)

Determination of pain and response to methylprednisolone in Guillain-Barré syndrome
por: Ruts, Liselotte, et al.
Publicado: (2007)

Diagnosis and treatment of chronic inflammatory demyelinating polyradiculoneuropathy in clinical practice: A survey among Dutch neurologists
por: Broers, Merel C., et al.
Publicado: (2020)

IVIG Treatment and Prognosis in Guillain–Barré Syndrome
por: van Doorn, Pieter A., et al.
Publicado: (2010)

Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection
por: van der Zwan, Marieke, et al.
Publicado: (2020)

The effects of vasoactive intestinal peptide in the rat model of experimental autoimmune neuritis and the implications for treatment of acute inflammatory demyelinating polyradiculoneuropathy or Guillain–Barré syndrome
por: Jiao, Hong, et al.
Publicado: (2018)

Tracheostomy or Not: Prediction of Prolonged Mechanical Ventilation in Guillain–Barré Syndrome
por: Walgaard, Christa, et al.
Publicado: (2016)

Hospital Admissions, Transfers and Costs of Guillain-Barré Syndrome
por: van Leeuwen, Nikki, et al.
Publicado: (2016)

Diagnostic challenges in chronic inflammatory demyelinating polyradiculoneuropathy
por: Eftimov, Filip, et al.
Publicado: (2020)

Chronic Inflammatory or Chronic Inflammatory Demyelinating Polyradiculoneuropathy?
por: Vallat, Jean-Michel, et al.
Publicado: (2022)

IVIg‐induced plasmablasts in patients with Guillain‐Barré syndrome
por: Brem, Maarten D., et al.
Publicado: (2018)

Antibodies to Heteromeric Glycolipid Complexes in Guillain-Barré Syndrome
por: Rinaldi, Simon, et al.
Publicado: (2013)

Chronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy
por: Khadilkar, Satish V., et al.
Publicado: (2011)

Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype
por: Mathey, Emily K, et al.
Publicado: (2015)

Pyrexia-associated Relapse in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
por: Ueda, Jun, et al.
Publicado: (2018)

Chronic inflammatory demyelinating polyradiculoneuropathy: A case report
por: Hu, Bolin, et al.
Publicado: (2018)

The immune response and aging in chronic inflammatory demyelinating polyradiculoneuropathy
por: Hagen, Kathleen M., et al.
Publicado: (2021)

A patient’s experience with chronic inflammatory demyelinating polyradiculoneuropathy
por: Saigle, Victoria
Publicado: (2023)

Comparison of electrophysiological findings in axonal and demyelinating Guillain-Barre syndrome
por: Yadegari, Samira, et al.
Publicado: (2014)

The Correlation Among the Immunoglobulin G Synthesis Rate, IgG Index and Albumin Quotient in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyradiculoneuropathy: A Retrospective Case–Control Study
por: Tu, Yu, et al.
Publicado: (2021)

Efficient design and analysis of randomized controlled trials in rare neurological diseases: An example in Guillain-Barré syndrome
por: van Leeuwen, Nikki, et al.
Publicado: (2019)

Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain–Barré Syndrome
por: Fokkink, Willem Jan R., et al.
Publicado: (2022)

Human Endogenous Retrovirus and Neuroinflammation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy
por: Faucard, Raphaël, et al.
Publicado: (2016)

Stance Postural Strategies in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy
por: Rinalduzzi, Steno, et al.
Publicado: (2016)

Neuroimaging markers of clinical progression in chronic inflammatory demyelinating polyradiculoneuropathy
por: Pitarokoili, Kalliopi, et al.
Publicado: (2019)

Alternatives to intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyradiculoneuropathy
por: Castle, Dan, et al.
Publicado: (2019)

Inhaled Solvent Abuse Mimicking Chronic Inflammatory Demyelinating Polyradiculoneuropathy
por: Thulasirajah, Salini, et al.
Publicado: (2020)

Pembrolizumab-Induced Myocarditis and Delayed Acute Inflammatory Demyelinating Polyradiculoneuropathy
por: Dalal, Fazal, et al.
Publicado: (2022)

Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Diabetes: A Case Report
por: Ferraz de Oliveira, Inês, et al.
Publicado: (2022)

Idiopathic Intracranial Hypertension Secondary to Chronic Inflammatory Demyelinating Polyradiculoneuropathy
por: Gül, Sedat, et al.
Publicado: (2023)

Changes in motor nerve excitability in acute phase Guillain‐Barré syndrome
por: Drenthen, Judith, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mhrndl9s0v6qes194rpsoivtnr